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ABSTRACT
The double membrane nuclear envelope (NE), which is contiguous with the ER, contains nuclear
pore complexes (NPCs) – the channels for nucleocytoplasmic transport, and the nuclear lamina
(NL) – a scaffold for NE and chromatin organization. Since numerous human diseases linked to NE
proteins occur in mesenchyme-derived cells, we used proteomics to characterize NE and other
subcellular fractions isolated from mesenchymal stem cells and from adipocytes and myocytes.
Based on spectral abundance, we calculated enrichment scores for proteins in the NE fractions.
We demonstrated by quantitative immunofluorescence microscopy that five little-characterized
proteins with high enrichment scores are substantially concentrated at the NE, with Itprip exposed
at the outer nuclear membrane, Smpd4 enriched at the NPC, and Mfsd10, Tmx4, and Arl6ip6 likely
residing in the inner nuclear membrane. These proteins provide new focal points for studying the
functions of the NE. Moreover, our datasets provide a resource for evaluating additional potential
NE proteins.
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Introduction
The nuclear envelope (NE), which forms the mem-
brane boundary of the nucleus, segregates the genome
and chromosome-associated metabolism from the
cytoplasm. It is a specialized endoplasmic reticulum
(ER) sub-domain containing an outer nuclear mem-
brane (ONM) that has continuity and functional
similarity with the peripheral ER, and an inner
nuclear membrane (INM) with distinctive properties
[1,2]. The lipid bilayers of the ONM and INM are
joined at nuclear pore complexes (NPCs), massive
supramolecular protein assemblies that provide pas-
sageways for molecular transport across the NE [3,4].
The NPC is formed from multiple copies of ~30
polypeptides (termed nucleoporins or Nups).
A subset of Nups provide scaffolding for the NPC,
whereas others, particularly those containing Phe-Gly
repeats (termed ‘FG Nups’), form a diffusion barrier
across the NPC and provide binding sites for nuclear
transport receptors [3–5].
In higher eukaryotic cells, the INM is lined by the
nuclear lamina (NL) – a protein scaffold whose
backbone contains a polymer of nuclear lamins, type
V intermediate filament proteins [6,7]. Three major
lamin subtypes are expressed in the majority of mam-
malian cells: lamins A/C, B1 and B2 [6,7]. In addition
to lamins, at least 20 widely expressed polypeptides
are concentrated at the INM [1,6,7]. The NL has been
implicated in nuclear structure andmechanics, tether-
ing of heterochromatin and the cytoplasmic cytoske-
leton to the NE, and regulation of signaling and gene
expression [1,6,7]. Consistent with this wide array of
functions, mutations in the genes for lamins and
associated proteins have been found to cause
a spectrum of human diseases (termed ‘laminopa-
thies’) [8,9]. Many of these diseases target specific
tissues, commonly of mesenchymal origin.
Most of the known INM-enriched proteins have
one or more transmembrane (TM) segments [1,10].
Following insertion in the peripheral ER and ONM,
these TM proteins are thought to become concen-
trated at the INM by lateral diffusion in the lipid
bilayer around theNPC, in conjunctionwith binding
to the NL and/or other intranuclear components
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[10,11]. Movement is bi-directional, and the degree
to which specific NE proteins are localized to the
INM vs peripheral ER can vary with different cell
types or physiological states [12,13]. Consistent with
this diffusion-retention model, ~1/3 of transmem-
brane proteins in the yeast genome have the ability to
reach the INM, even though most do not appear to
be concentrated there or to have nucleus-specific
functions [14]. The principles of the diffusion-
retention model also appear to specify NE localiza-
tion of the LINC complex, an interconnected assem-
bly of TM proteins spanning the INM (SUN-domain
proteins) andONM (nesprins) that is responsible for
attaching cytoplasmic cytoskeletal filaments to the
NL [15,16].
The detailed protein composition of the NL/INM
inmammals remains incompletely understood, and it
is likely that low-abundance proteins and/or those
with cell type-selective expression patterns remain to
be revealed. Proteomics analysis has identified
numerous TM proteins in isolated NE fractions of
different cell types [17–19], but it remains unclear
whether most of these proteins are concentrated at
the NE relative to the peripheral ER, or are more
general ER residents that by default can diffuse into
the contiguous nuclear membranes. An important
goal that remains is a comprehensive characterization
of proteins that are concentrated at the NE relative to
the peripheral ER, as these proteins de facto are likely
to have specific functions for the nucleus.
In this study, we used proteomics to characterize
NEs and other subcellular fractions isolated from
cultured mesenchymal stem cells (MSCs), and from
correspondingly differentiated adipocytes and myo-
cytes. We implemented a scoring system with the
datasets to describe the relative enrichment of indivi-
dual proteins in the NE fraction. This system accu-
rately represented most of the TM proteins known to
be concentrated at the NE, supporting its predictive
value for new candidates.We selected five of the high-
scoring new candidates expressed in all three
mesenchymal cell types for direct evaluation by quan-
titative immunofluorescence microscopy. Our results
revealed that all of these are substantially concentrated
at the NE: one is enriched at the NPC, one occurs in
theONM, and the remainder appear to be localized to
the INM. The sequence homologies and other fea-
tures of these proteins indicate that they are new
windows for understanding the functions and
dynamics of the NE. Our datasets provide a resource
for evaluating the potential NE localization of mem-
brane proteins detected in proteomics and other
screens, and should facilitate the identification of
additional NE-concentrated proteins.
Results
The frequent manifestation of laminopathies in
cells of mesenchymal cells [8,9] prompted us to
carry out NE proteomics on the murine C3H10T1/
2 (C3H) MSC line and differentiated derivatives.
Using undifferentiated C3H cells (U), together
with differentiated adipocytes (A) and myocytes
(M), we isolated three subcellular fractions for
proteomic analysis: NE, nuclear contents (NC)
and cytoplasmic membranes (CM) (Figure 1;
Materials and Methods). The NE and NC fractions
were obtained by nuclease digestion of isolated
nuclei followed by treatment with 0.5 M NaCl
and sedimentation to yield the NE (pellet) and
NC (supernatant) fractions. The CM fraction was
obtained by flotation of membranes from a post-
nuclear supernatant to a low-density zone of
a sucrose gradient, a procedure that enriches for
secretory pathway organelles (Golgi, plasma mem-
brane, and endosomes/lysosomes). We optimized
our cell lysis and fractionation methods using
Western blotting to follow marker proteins for
various organelles (see Materials and Methods).
The proteomics analysis of the fractions provided
a detailed measure of the relative abundance of
benchmark and contaminant proteins in each frac-
tion, as considered below.
We used multidimensional protein identification
technology (MudPIT [20]; see Materials and
Methods) for analyzing the fractions from the three
cell types. Collectively this involved 3–4 mass spectro-
metry runs for each fraction and cell type, and identi-
fied 7938 proteins (Table S1). Approximately 60% of
these were detected in all three cell types, whereas
~6–8% were uniquely found in only one of the three
cells (Figure 2(a); Table S1). As expected, proteins
diagnostic of differentiated adipocytes (e.g. long
chain fatty acid CoA ligase 1, perilipin 1) and myo-
cytes (myosin 3 heavy chain, titin) were strongly
induced in the respective differentiated cells, based
on NSAF (normalized spectral abundance factor
[21]) values (Table S1). To evaluate the abundance
NUCLEUS 127
of individual proteins in the NE fraction relative to
NC and CM, we calculated a NE enrichment score
(termed ‘score’ below) based on NSAF values (see
Materials and Methods). With this method, proteins
that were detected only in the NE fraction had a score
of 1, proteins that were found only in NC and/or CM
had a score of 0, and proteins found both in the NE
and in other fractions had intermediate scores. Scores
were calculated only for proteins that were detected
with 5 ormore spectral counts in a particular cell type,
since predictions are less reliable with low spectral
detection.
Only 3% of the proteins in U cells had scores ≥ 0.7
(Figure 2(b), top). By contrast, ~15–20% of the pro-
teins scored in this range in the A andM cells. When
only proteins with annotated TM segments were
considered (roughly 20% of all proteins detected),
the protein percentage scoring ≥ 0.7 was more simi-
lar in the three cell types (between 4–9%; Figure 2(b),
bottom). Thus, the high-scoring protein set of U cells
is relatively enriched in TM proteins, as compared to
those of A and M cells. These differences are corre-
lated with higher levels of tubulin in A and M cells
and less efficient extraction of non-TM cytoplasmic
and intranuclear proteins from the NE fraction of
these cells, as compared to U (Table S1).
We evaluated our scoring system using sets of
benchmark proteins with well-defined membrane
localizations (Table S2). The NE benchmarks, com-
prising 30 Nups and 23 INM proteins, included 22
proteins with TM segments. Other benchmarks
involved sets of ~15–20 abundant TM proteins
enriched in different cytoplasmic membrane com-
partments: peripheral ER, Golgi, mitochondria and
the plasma membrane/endosome/lysosome system
(Figure 2(c) and Table S2). Most NE proteins with
TM segments had a high score (> 0.7) in all three cell
types. Notable exceptions with lower scores
(~0.5–0.7) were emerin and Tmem43 (LUMA),
which are known to be partially localized to the per-
ipheral ER in certain cell types and/or physiological
states [12,13,22,23]. The benchmark TM proteins of
the peripheral ER had scores ranging from 0.2–0.7,
clustering around a mean value of ~0.5, although
a few proteins characteristic of sheet ER (e.g. Sec11α,
Sec61β) [24], had higher scores (~0.7–0.8) in one or
more cell types. TM proteins of Golgi, plasma mem-
brane/endosome/lysosome and mitochondria mostly
had scores between 0.1–0.5, consistent with Western
blot analysis of the NE fractionation (data not shown).
Many of the benchmark NE proteins lacking anno-
tated TM segments also had high scores (> 0.7) in the
































Figure 1. Isolation of subcellular fractions from U, A and M cells. Schematic diagram of the subcellular fractionation methods used to
isolate NE, NC and CM fractions.
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three cell types, including B-type lamins, the NL-
associated proteins Prr14 [25] and Gmcl1 [26],
many Nups and the NPC-associated protein
Mcm3ap [27]. NE proteins with somewhat lower
scores included A-type lamins and ~10 Nups lacking
TM segments, which correspondingly were relatively
abundant in the NC fraction. These results are con-
sistent with the well-established existence of intranuc-
lear pools of lamins A/C [28] and Nups [29] separate
from the NL and NPC, respectively. The scores for
almost all NE markers in A were lower than their
corresponding scores in U and M cells (Table S2),
coinciding with relatively higher levels of these pro-
teins in the NC fraction (Table S1). This may reflect
greater fragility of the NE of A cells, resulting in
release of NE fragments to NC during fractionation.
The non-TM protein datasets included low-
abundance components with high scores in one or
two cell types. Many of these have known regulatory,
enzymatic or structural roles in the nuclear interior,
cytosol or extracellular matrix. Although some of
these also may function at the NE, we expect that
most are not strongly concentrated at the NE in situ.
The high scores could reflect either intrinsic limita-
tions of MudPIT proteomics (see Discussion),
adsorption to the NE during isolation, or association
with co-fractionating structures such as the inter-
mediate filament protein synemin or the extracellu-
lar matrix components collagen or fibronectin.
The above considerations indicate that our scoring
system can most effectively predict new NE-
concentrated proteins with TM segments. We per-
formed unsupervised hierarchical clustering to
further analyze the set of 243 TM proteins with scores
higher than 0.5, sorting the proteins from the three
cell types into eight clusters (Figure 3(a) and Table
S3). The cluster with high scores in all three cell types
(Figure 3(a)) was predominated by well-established
NE-concentrated proteins (see Table S2). It also












































































































Figure 2. Analysis of overall results from the proteomic analysis. (a) Venn diagram representing proteins detected in U, A and M cells
and the overlap of the datasets. (b) Graphs plotting the NE enrichment scores vs number of proteins in U, A and M cells for datasets
representing all proteins (Total) or datasets representing only annotated TM proteins (TM). (c) Box and whisker plots depicting NE
enrichment scores for benchmark proteins of the NE, NL/INM and the cytoplasmic membrane compartments indicated in U,
A and M cells. See Table S2 for scores associated with specific proteins.
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to be concentrated at the NE, which represent new
candidates. We selected four members of this group
to analyze: Arl6ip6, Mfsd10, Smpd4 and Tmx4
(Figure 3(b)). We added a fifth high-scoring protein
found in the three cell types (Itprip) to the query
group, since it is predicted to have a TM domain by
the CCTOP algorithm and is homologous to Itpripl1
and Itpripl2, which both contain a curated TM seg-
ment (Uniprot).We also analyzed anothermember of
the cluster that recently was shown to be concentrated
at the NE, Vrk2 [30]. A diagrammatic representation
of these proteins, with the position of the epitope tag
and predicted TM segments, is shown in Figure 3(c).
The specific peptides detected for these proteins are
listed in Table S3.
To evaluate whether the five candidates are con-
centrated at the NE relative to the peripheral ER, we
prepared populations of C3H cells stably transduced
with lentiviral vectors expressing epitope-tagged ver-
sions of these proteins. After verifying that the V5-
tagged recombinant proteins migrated at their pre-
dicted sizes by Western blotting (Figure 3(c), Table
S5), we examined the behavior of the ectopically
expressed proteins using a one-step fractionation of
cell homogenates to obtain a low speed pellet
enriched in nuclei, and a supernatant containing
cytoplasmic membranes (Fig. S1). Quantification
by Western blotting showed that ectopic Sec61β
was enriched in the post-nuclear supernatant,
whereas ectopic Lem2 was concentrated in the
nuclear pellet. Like Lem2, ectopic Itprip, Mfsd10
and Smpd4 were significantly enriched in the
nuclear fraction. However, ectopic Arl6ip6, Tmx4
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Figure 3. Cluster analysis, selection of target set and characterization of target- transduced cell populations. (a) Depiction of cluster
analysis of annotated TM proteins in the three cell types. NE enrichment scores are color coded as indicated. Right panel: List of
proteins in cluster 8. (b) Proteins selected for analysis, together with a description of each protein, the number of predicted TM
domains, spectral counts and NE enrichment score obtained in each cell type. (c) Left: Western blot analysis of C3H cell populations
stably expressing the candidates as detected by anti-V5 antibodies. Migration of molecular weight markers is indicated on left. Right:
Schematic representation of the size of the proteins, the position of the epitope tag, and predicted transmembrane segment(s) using
CCTOP program.
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the two fractions. This could reflect the substantial
amounts of these proteins in the peripheral ER seen
by immunolocalization in some growth and expres-
sion conditions (below) and/or hypothetical release
from NE binding sites and redistribution to the
peripheral ER during the hypotonic swelling of
cells preceding homogenization.
We used immunofluorescence staining and con-
focal microscopy to more incisively analyze the
subcellular localization of the ectopically expressed
proteins. We compared the ectopic proteins to two
endogenous markers, lamin A and the pan-ER
transmembrane protein calnexin [24] (Figure 4(a)
and Figs. S2-S4). With appropriate placement of
the V5 epitope tag (summarized in Table S5) and
transduction of cells with a low lentiviral MOI
(multiplicity of infection), we observed that all
five of the new candidates were substantially
more concentrated at the NE than in cytoplasmic
regions in most cells (Figure 4(a) and Fig. S3). This
resembled the localization of ectopically expressed
Lem2 and emerin (Figure 4(a) and Fig. S2), and
contrasted with the pan-ER distribution of ectopic
Sec61β [24] (Fig. S2). The control protein Vrk2
clearly was more concentrated at the NE than
calnexin, but it was present at relatively high levels
in the peripheral ER as well, consistent with pre-
vious work (Figure 4(a) and Fig. S3) [30]. Also, the
NE-concentrated staining pattern shown for
Arl6ip6 (Figure 4(a) and Fig. S3) was typically
observed in moderately dense cell cultures. With
lower cell densities, considerably higher levels of
peripheral ER staining were seen, in addition to
the NE labeling (Fig. S4D-E).
We implemented an unbiased method to quantify
the levels of NE localization of ectopic constructs,
focusing on cells representing the lower half of the
expression spectrum. The method involved compar-
ing the fluorescence intensity ratio of the epitope tag/
endogenous calnexin at the NE, to the epitope tag/
calnexin ratio in a peripheral ER zone surrounding the
nucleus (see Materials and Methods). This approach
revealed that ectopically expressed emerin and Lem2
were ~3–6-fold concentrated at the NE relative to the
peripheral ER (Figure 4(b)). The five NE candidates
were 1.7–3.5-fold concentrated at the NE, whereas
Vrk2 showed a lower (1.3-fold) but statistically signif-
icant NE concentration (Figure 4(b)). If anything, the
peripheral ER levels calculated for the ectopic
constructs over-represent the native levels of these
proteins in the peripheral ER, due to potential artefacts
of ectopic protein over-expression (discussed below).
Unfortunately, wewere unable to compare the expres-
sion of the ectopically expressed candidates and their
endogenous counterparts by Western blotting, due to
the lack of convincing detection with commercial
antibodies (see Materials and Methods).
During the course of this analysis, it became evi-
dent that the localization patterns of the ectopic pro-
teins changed with their expression levels, with
strongly NE-selective labeling associated preferen-
tially with low expression. This was particularly con-
spicuous for Tmx4 and Smpd4. Whereas Tmx4 was
highly concentrated at the NE compared to the per-
ipheral ER in cell populations expressing compara-
tively low ectopic protein, it was uniformly localized
throughout the ER/NE system in cells expressing high
levels (Fig. S4A-C). Also, the selective NE targeting of
ectopic Smpd4 that was evident with low expression
at early times after lentiviral transduction (Figure 4(a)
and Fig. S5) was largely obscured by numerous cyto-
plasmic Smpd4 foci that accumulated in long-term
expressing cells (Fig. S5). Consistent with the diffu-
sion-retentionmodel for NE localization, these results
suggest that saturation of NE binding sites by over-
expression of ectopic constructs results in net redis-
tribution to the contiguous peripheral ER and/or
appearance in cytoplasmic aggregates.
We used cell permeabilization with low/high con-
centrations of digitonin to analyze whether the newly
identified NE-concentrated proteins are exposed to
the ONM, or reside in a sequestered space at the INM
or NPC (Figure 5(a)). With this technique (Fig. S6A),
low concentrations of digitonin permeabilize the
plasma membrane and allow antibody access to the
cytosolic space and ONM, but leave the ER and NE
intact [31]. Conversely, high concentrations of digito-
nin fully permeabilize the NE and allow antibody
access to proteins of the INM and NPC-associated
membrane as well. We validated this method in C3H
cells by antibody labeling of calnexin and Lem2 (Fig.
S6B): only the cytosol-exposed epitopes recognized by
the calnexin antibody were accessible with low digi-
tonin, but both calnexin and ectopically expressed
Lem2 (concentrated at the INM) were labeled after
cell treatment with either high digitonin or Triton
X-100. When applied to analysis of the five new NE
proteins and Vrk2, low digitonin treatment yielded
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strong NE staining only for Itprip. In addition, label-
ing of the relatively minor peripheral ER pools of
Arl6ip6, Mfsd10, Tmx4 and Vrk2 also was evident
(Figure 5), suggesting that the V5 epitope tag on these
proteins was exposed to the cytosolic/nucleoplasmic
space. This topology inference also was supported by
phosphorylation site data for these proteins (see
legend for Fig. S10). Treatment with high digitonin
yielded strong NE labeling of the latter four proteins,
as well as strong staining of Smpd4 at both theNE and
in cytoplasmic foci. These results indicate that Itprip is
























































Figure 4. Immunofluorescence localization of ectopically expressed target proteins. (a) Micrographs of representative cells from
ectopically expressing populations that were co-labeled with antibodies to the V5 epitope tag (to detect indicated targets), calnexin
and lamin A. DNA staining (DAPI) and a merge of V5 and calnexin labeling is shown in the right panels. Lem2 and Vrk2 are included
as positive controls. Scale bars, 10μm. (b) Graph showing relative enrichment of targets in the NE, determined by ratio of V5/calnexin
staining in the NE vs the V5/calnexin ratio in the immediately adjacent peripheral ER. Quantification is described in Materials and
Methods. Red line indicates the V5/calnexin ratio in the NE vs peripheral ER for ectopically expressed Sec61β. Stably transduced
populations were examined in all cases except for Smpd4, which was visualized in transiently transduced cells (see Materials and
Methods).
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proteins are located at membrane-sequestered NE
regions. Since Arl6ip6, Mfsd10 and Tmx4 showed
relatively uniform nuclear rim staining similar to
Vrk2, it is likely that these proteins are localized at
the INM.
The NE staining seen for both Smpd4 and Itprip
was conspicuously less uniform than that of the other
proteins analyzed, particularly in tangential views.We
found that Smpd4 was localized to small puncta at the
nuclear surface (Figure 5(b) and Fig. S7). In substan-
tial part, these puncta co-localized with NPCs, as
detected by an antibody to FG-repeat Nups (Figure
5(b); Pearson correlation coefficient R = 0.5).
However, the Smpd4 intensity in different NPC
puncta varied considerably, and some of the Smpd4
puncta at the NE had little or no Nup staining.
Surprisingly, many of the Smpd4 foci found in the
cytoplasm of both transiently transduced and stably
expressing cell populations also were strongly labeled
with the antibody to FG Nups (Fig. S5). This suggests
that FGNups may be recruited to ectopic cytoplasmic
foci containing Smpd4. This is reminiscent of experi-
ments involving ectopic overexpression of the trans-








































































































Figure 5. Immunofluorescence analysis of the localization of target proteins with respect to NE substructure. (a) Representative
images obtained with antibody staining after cell permeabilization with low or high concentrations of digitonin (DG). C3H cells
ectopically expressing the depicted targets were incubated with antibodies to the V5 tag, calnexin and lamin A. Merged images of
V5 and calnexin staining are shown on the right. (b, c) High resolution immunofluorescence images, obtained with Airyscan, of cells
expressing ectopic Smpd4 or Itprip as indicated. Cells were co-labeled with antibodies to V5 and RL1, a monoclonal antibody
recognizing FG repeat Nups of the NPC [63], after fixation and permeabilization with standard conditions. Pearson’s correlation
coefficient R (indicated) shows substantial co-localization between V5-Smpd4 and the NPC but no significant co-localization between
Itprip-V5 and the NPC. Right panels show higher magnification views of areas indicated by boxes. In cells expressing V5-Smpd4,
examples of foci co-labeled with RL1 and anti-V5 are indicated (arrowheads). All panels: scale bars, 10μm.
NUCLEUS 133
foci containing both Pom121 and FG Nups [32].
These results, together with data revealing interac-
tions of Smpd4 with several Nups in pull-down assays
[33], support a physiologically relevant interaction
between Smpd4 and Nups, and strongly suggest that
at least much of Smpd4 is associated with the NPC.
The non-uniform co-localization of Smpd4 and FG
Nups at the nuclear surface in part could reflect
uneven association of ectopic Smpd4 with different
populations of NPCs, or assembly of the ectopic pro-
tein into non-native NPC-related structures at the
nuclear surface.
The distribution of Itprip on the nuclear surface
was qualitatively different from the Smpd4 staining
(Figure 5(b-c) and Fig. S7), as it commonly appeared
in linear arrays of puncta instead of the more distrib-
uted NPC-like pattern. The Itprip puncta did not co-
localize with FG Nups (Figure 5(c)), or with nesprin-
1, nesprin-2, nesprin-3 or Sun2 (Fig. S8). Nonetheless,
due to the potential limitations of antibody-based
localization, it remains possible that Itprip is asso-
ciated with a subset of poorly detected LINC complex
components.
We next analyzed whether the five newly identified
NE proteins and Vrk2 are concentrated at the NE in
differentiated adipocytes and myocytes (Figure 6), as
suggested by their high proteomics scores. We were
able to visualize Arl6ip6, Itprip, Smpd4, Tmx4 and
Vrk2 in differentiated adipocytes, and in all cases
obtained strong labeling of the NE with little or no
peripheral ER/cytoplasmic staining. We achieved
myogenic differentiation of cells stably transduced
with Tmx4, Itprip and Arl6ip6, but not with the
other proteins (see Materials and Methods). In all
three cases, we observed robust NE-concentrated
staining. As an additional model for NE targeting,
we analyzed stably transduced populations of the
human U2OS osteosarcoma cell line. In all cases, we
observed strong targeting of the candidates to the NE
(Fig. S9). Together these results indicate that the five
newly characterized proteins have the capacity to
concentrate at the NE in a variety of different cell
types, and likely are widespread NE-enriched
components.
Discussion
Here we used MudPIT analysis of subcellular frac-
tions to identify five previously unrecognized TM
proteins that are strongly concentrated at the NE:
Arl6ip6, Itprip, Mfsd10, Smpd4 and Tmx4.
Immunofluorescence microscopy with epitope
accessibility analysis revealed that Itprip is located
at the ONM and that much of Smpd4 is concen-
trated at the NPC (Fig. S10). The experiments also
suggested that the other three proteins reside in the
INM (Fig. S10). Although we focused our analysis on
mesenchymal stem cells, adipocytes and myocytes,
we found that these proteins also target strongly to
the NE in U2OS cells. RNA-seq databases indicate
that the five proteins are expressed broadly in human
and mouse tissues, and all have been detected in
HeLa cells by proteomics [33]. Thus, these probably
are widespread NE components.
The proteomics scoring system we used to eval-
uate NE enrichment was validated by examination
of benchmark proteins for several cytoplasmic
membrane compartments, and provided a strong
framework for our efforts. One caveat of this strat-
egy is that MudPIT proteomics only semi-
quantitatively represents the relative abundance of
a particular protein in different subcellular frac-
tions, with higher spectral detection increasing the
reliability [34]. Thus, scores based on relatively low
spectral counts should be interpreted cautiously.
We found that validation of NE proteins by ectopic
expression and confocal microscopy was most accu-
rately achieved using stably transduced cell popula-
tions, except in the case of Smpd4 (see Materials and
Methods).We deem it essential to quantify the relative
concentration of the ectopic target at the NE vs the
peripheral ER using an internal TM marker that is
evenly represented in both membrane systems, such
as calnexin. The quantification method we employed
(Materials and Methods) provides greater sampling
depth than the commonly used line-scanning of con-
focal sections, which may be subject to user bias. We
emphasize that high levels of ectopic protein over-
expression in some cases can mask NE localization,
as we have observed for Tmx4. This can explain the
discrepancy between our demonstration that Tmx4 is
concentrated at the NE with relatively low ectopic
expression, and previously published work revealing
a pan-ER distribution of ectopic Tmx4 [35,36],
a patternwe also observedwith highTmx4 expression.
Aside from the sample set we analyzed, we consider
it likely that some additional TM proteins with high
scores in our datawill turn out to beNE-concentrated,
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even in cases where database annotations suggest
otherwise. For example, Pigb (not detected in our
analysis) is known to be a mannosyltransferase
involved in synthesis of the GPI anchor precursor
and is annotated in UniProtKB as a general ER pro-
tein, but was recently shown to be strongly concen-
trated at the NE inDrosophila [37]. Here we analyzed
proteins with high NE enrichment scores in all three
cell types, which appeared in one of the clusters. Some
of the proteins in other clusters, which have high
scores in one or two of the cell types, might be con-
centrated at the NE is a differentiation state-selective
pattern.
The group of high-scoring non-TM proteins in
our datasets also is likely to contain proteins con-
centrated at the NE in mesenchymal cells. NE
association has been suggested for some of these,




































































Figure 6. Immunofluorescence analysis of the localization of target proteins in adipocytes and myocytes. (a) C3H cells stably
transduced with the indicated constructs were differentiated into adipocytes and co-labeled with antibodies to the V5 epitope tag,
calnexin and lamins A. DNA staining (DAPI) and a merge of V5 and calnexin labeling is shown in the right panels. (b) C2C12
myoblasts that were stably transduced with the indicated constructs were differentiated into myotubes and labeled as in (a). Scale
bars, 10μm.
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Ptgs2 [39] and the choline phosphate cytidylyl-
transferase Pcyt1a [40,41]. However, we consider
our datasets and scoring system most useful for
the analysis of TM proteins.
Sequence analysis of the newly identified NE pro-
teins suggests potential roles in nuclear regulation
and membrane dynamics. The most evolutionarily
conserved protein of this group is Mfsd10, a member
of the ancientMajor Facilitator Superfamily ofmem-
brane solute transporters. Mfsd10 was proposed to
be a cellular efflux pump for organic anions and
nonsteroidal anti-inflammatory drugs [42], although
its transport properties have not been directly ana-
lyzed. Interestingly, the highest Psi-BLAST scores for
Mfsd10 involve tetracycline efflux pumps of gram
negative bacteria (e.g. 31% identity/45% similarity
over 90% of Mfsd10 sequence with the TetA gene
of S. marcescens). This raises the possibility that
Mfsd10 may transport toxic metabolites and/or
xenobiotics across the INM to the ER lumen, as
a means of efficiently funneling deleterious com-
pounds out of the nuclear environment.
Unexpectedly, we found the sphingomyelin
phosphodiesterase Smpd4 [43] to be concentrated
at the NPC. Smpd4 releases ceramide, a signaling
molecule itself and biosynthetic precursor to the
signaling lipid S1P [44] that is known to act in the
nucleus to inhibit HDACs [45,46] and to stabilize
telomerase [47]. The NPC association of Smpd4
raises the possibility that the production of S1P in
the nucleus might be linked to transport activity at
the NPC. Smpd4 also might have a role in lipid
bilayer dynamics at the NE. For example, if Smpd4
were localized on the INM side of the NPC, sphin-
gomyelin hydrolysis could reduce lipid head group
packing on the nucleoplasmic leaflet of the INM to
drive the membrane association and activation of
Pcyt1a [40] or the pro-inflammatory phospholi-
pase A2 [48]. Sphingomyelin hydrolysis also
could promote local concave membrane curvature,
which accompanies the process of NPC insertion
in the interphase NE [49].
Itprip was the only protein of the group found to be
localized to the ONM. A previous study reported that
Itprip binds the inositol triphosphate receptor cal-
cium channels and negatively regulates their activity
in vitro [50]. Thus, Itprip could potentially function in
localized regulation of calcium fluxes near the
nucleus. Interestingly, an ~300 residue region of
Itprip comprises a Mab-21 nucleotidyltransferase
fold (Uniprot) found in multiple proteins [51] includ-
ing cGAS, a cytosolic enzyme involved in the sensing
of cytoplasmic DNA in innate immunity. The con-
centration of Itprip at the NE could be explainedmost
simply by an interaction with one or more nesprins,
which themselves are concentrated at the NE due to
transmembrane associations with SUN-domain pro-
teins [15,16]. However, we were unable to detect co-
localization with nesprin-1, nesprin-2, nesprin-3 or
Sun2 using the antibodies that were available.
Nonetheless, a potential interaction of Itprip with
LINC components merits further analysis.
The properties of Tmx4 and Arl6ip6 are consis-
tent with a role in regulating NE structure. The
thioredoxin domain of Tmx4 is likely localized to
the NE lumen, since it occurs between an
N-terminal signal sequence and the single TM
segment. This suggests a potential role in regulat-
ing the luminal aspects of NE specific structures,
such as the LINC complex and associated torsinA,
both of which may be regulated by disulfide oxida-
tion/reduction [52,53]. Arl6ip6 is a susceptibility
locus for ischemic stroke [54]. It lacks enzyme-
related domains, but does show physical interac-
tions in proteome-wide pull-down screens with
a number of proteins involved in membrane vesi-
cle formation/targeting [33,55], a process that is
involved in NE resealing and repair.
In conclusion, the set of new NE proteins iden-
tified in this study provide new avenues for study-
ing the dynamics and functions of the NE. It will
be useful to extend the methodology used in this
study to the analysis of other cell types, where we
expect that additional NE-concentrated proteins
with interesting properties will be identified.
Materials and methods
Cell culture
C3H/10T1/2 (C3H), C2C12, U2OS, and 293T cells
were all acquired from the American Type Culture
Collection (ATCC). C3H, C2C12, and 293T cells
were grown in high glucose Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco) supplemented
with 10% fetal bovine serum (FBS) (Gibco), 1%
penicillin/streptomycin/glutamine cocktail (P/S/G)
(Gibco), and 1% minimum essential medium non-
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essential amino acids (NEAA) (Gibco). U2OS cells
were grown in McCoy’s 5A medium (Gibco) sup-
plemented with 10% FBS and 1% P/S/G. All cells
were maintained at 37°C in 5% CO2.
Cell differentiation
For adipogenesis, C3H cells were grown on plates
coated with 0.2% gelatin (Sigma) and allowed to
reach 100% confluency. Growth medium was then
changed to C3H differentiation medium consisting
of DMEM supplemented with 10% iron-
supplemented bovine calf serum (HyClone) and
1% P/S/G. After 48 hours, medium was changed
to pre-adipocyte differentiation medium consist-
ing of DMEM-L-Glutamax (Gibco) supplemented
with 10% FBS (Gemini), 1% P/S/G, 5 μg/mL
human insulin (Sigma), 0.5 mM 3-isobutyl-
1-methylxanthine (IBMX) (Sigma), 1 μM
Dexamethasone (Sigma), and 2 μM Rosiglitazone
(Cayman). After another 48 hours, media was
changed to adipocyte differentiation medium con-
sisting of DMEM-L-Glutamax supplemented with
10% FBS (Gemini), 1% P/S/G, and 5 μg/mL
human insulin. Adipocyte differentiation medium
was replaced every 2 to 3 days until terminal
differentiation (5 to 7 more days).
For C3H myogenesis, cells were grown in DMEM
supplemented with 10% FBS and 1% P/S/G. C3H cells
were transfected with 10 μg of a doxycycline-inducible
MyoD piggyBac transposon vector [56]. After
48 hours, cells with positive integration of the vector
were selected using 2 μg/mL puromycin (Invivogen)
for 24 hours. To initiate myotube differentiation, sta-
bly integrated populations of C3H cells were grown on
500 cm plates to 70% confluency and induced with
20 ng/mL doxycycline (Sigma) for 24 hours. Cells were
then changed to differentiation medium containing
DMEM with 2% donor equine serum (HyClone), 1%
ITS LiquidMedia Supplement (Sigma), and 1%P/S/G.
Differentiation media was replaced every 24–48 hours
until terminal differentiation (about 3 days).
For C2C12 myogenesis, cells were plated and
allowed to reach 90–95% confluency. Media was
then changed to DMEM supplemented with 1%
donor equine serum (HyClone), 1% P/S/G, and 1%
ITS Liquid Media Supplement (Sigma). Medium was
replaced every 48 hours until terminal differentiation
(4 to 5 days after initiation of myogenesis).
Subcellular fractionation
For subcellular fractionation, C3H cells were seeded in
500 cm2 plates and allowed to reach 90% confluency.
Plates were rinsed three times with ice-cold PBS, and
then three times with ice-cold homogenization buffer
(HB) (10 mM HEPES pH 7.8, 10 mM KCl, 1.5 mM
MgCl2, 0.1mMEGTA) containing 1mMDTT, 1mM
PMSF, and 1 μg/mL each of pepstatin, leupeptin, and
chymostatin. After these washes, cells were incubated
in HB for 15 minutes on ice. Cells were then scraped
off plates and were further disrupted by Dounce
homogenization with 18–20 strokes. The whole cell
homogenate was then layered on top of 2 mL shelf of
0.8 M sucrose in HB and centrifuged at 2000 rpm for
10 minutes at 4°C in a JS5.2 rotor with no brake to
yield a crude nuclear pellet and postnuclear super-
natant. The postnuclear supernatant comprising the
zone above the sucrose shelf, and pelleted nuclei were
each resuspended in 1.8 M sucrose (final concentra-
tion) in HB using a cannula. The resuspended nuclei
and postnuclear supernatant were layered in separate
ultra-clear 13.2 ml nitrocellulose centrifuge tubes on
top of a 1 mL layer of 2.0 M sucrose in HB. For the
nuclear gradient, HB was layered over the loading
zone to fill the nitrocellulose tube. For the postnuclear
supernatant gradient, 1 mL of 1.4 M sucrose in HB
was layered on top of the loading zone, followed by
HB to fill the tube. The gradients then were centri-
fuged at 35,000 rpm (210,000g) for 1 hour at 4°C with
no brake in an SW41Ti rotor. Nuclei that pelleted
through the 2.0 M sucrose were resuspended in HB
and Dounce homogenized with 2 strokes to disperse
aggregates. For the postnuclear supernatant gradient,
the HB/1.4 M sucrose interphase was collected and
saved as ‘cytoplasmic membranes’ (CM). Nuclei were
then incubated with 1 mM CaCl2 and 100 ku/mL
micrococcal nuclease (New England Biolabs) in HB
for 37°C for 15 minutes. Digested nuclei were then
placed on ice and NaCl was added to a final concen-
tration of 500 mM. The digested nuclei sample was
layered on top of 1 mL shelf of 0.8 M sucrose in HB
and centrifuged at 4000 rpm for 10 minutes at 4°C in
a JS5.2 rotor. A sample comprising the region above
the 0.8 M sucrose layer was collected and saved as
‘nuclear contents’ (NC). The NE fraction, comprising
the pellet, was collected by resuspension in HB.
During development of the fractionation method, we
monitored different organelles and cellular
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components at progressive steps of the isolation with
antibodies to the following markers: lamin B1 and the
INM resident LAP2β for the NE, histone H2B for
chromatin, calnexin for sheet and tubular ER [24],
Tim23 for mitochondria and Pex14 for peroxisomes.
For Western blot analysis of epitope-tagged
proteins with one-step fractionation, stably trans-
duced C3H cells were seeded in 15-cm plates and
allowed to reach 80% confluency. Cells were tryp-
sinized, rinsed and swollen as described above.
Cells were then passed through a 25g 1.5” needle
18–20 times with steady force. The homogenate
was then separated into a crude nuclear pellet and
postnuclear supernatant as described above. The
quality of homogenization was evaluated by
Western blotting to detect H2B and calnexin
prior to the densitometry analysis of V5-tagged
proteins. More than three fractionation experi-
ments were performed for each construct.
MudPIT proteomics
30 µg protein from each subcellular fraction (NE,
NC and CM), estimated by the Pierce BCA protein
assay (Thermo Fisher), was made up to a final
concentration of 4 M urea, 0.2% RapiGest SF
(Waters Corporation) and 100 mM NH4HCO3
pH 8.0. Proteins were reduced with Tris(2-carbox-
yethyl)phosphine hydrochloride and alkylated
with 2-Chloroacetamide. Next, proteins were
digested with 0.5 µg Lys-C (Wako) for 4 hours at
37°C, and then for 12 hours at 37°C in 2 M urea,
0.2% RapiGest SF, 100 mM NH4HCO3 pH 8.0,
1 mM CaCl2 with 1 µg trypsin (Promega).
Digested proteins were acidified with TFA to pH
< 2 and RapiGest SF was precipitated out. Each
fraction was loaded on individual MudPIT micro-
columns (2.5 cm SCX: 5 µm diameter, 125 Å
pores; and 2.5 cm C18 Aqua: 5 µm diameter,
125 Å pores; Phenomenex), and resolved across
an analytical column (15 cm C18 Aqua: 5 µm
diameter, 125 Å pores) (Phenomenex).
Analysis was performed using an Agilent 1200
HPLC pump and a Thermo LTQ-Orbitrap Velos
Pro using an in-house built electrospray stage.
MudPIT experiments were performed with steps
of 0%, 10%, 20%, 30%, 50%, 70%, 80%, 90%, 100%
buffer C and 90/10% buffer C/B [20], being run for
5 min at the beginning of each gradient of buffer
B. Electrospray was performed directly from the
analytical column by applying the ESI voltage at
a tee (150 mm ID) (Upchurch Scientific) [20].
Electrospray directly from the LC column was
done at 2.5 kV with an inlet capillary temperature
of 325°C. Data-dependent acquisition of tandem
mass spectra were performed with the following
settings: MS/MS on the 20 most intense ions per
precursor scan; 1 microscan; reject unassigned
charge state and charge state 1; dynamic exclusion
repeat count, 1; repeat duration, 30 second; exclu-
sion list size 500; and exclusion duration,
90 second.
Protein and peptide identification was done with
the Integrated Proteomics Pipeline – IP2 (Integrated
Proteomics Applications, Inc. http://www.integrated
proteomics.com/). Tandem mass spectra were
extracted (monoisotopic peaks) from raw files
using RawConverter [57] and were searched against
a UniProt SwissProtMus musculus database (release
2014_01) with reversed sequences using ProLuCID
[58,59]. The search space included all fully-tryptic
and half-tryptic peptide candidates with static mod-
ification of 57.02146 on cysteines. Peptide candidates
were filtered using DTASelect [60] at 1% protein
level False Discovery Rate, (parameters: -p 1 -y 1 –
trypstat –pfp 0.01 –extra –pI -DM 10 –DB –dm -in -t
0 –brief –quiet) [61,62].
To calculate a NE enrichment score, the sums of
the NSAF scores for each protein for NE, CM, and
NC fractions were calculated. The following equa-
tion was used to determine NE enrichment score,




e NSAFNEep þ NSAFCMep þ NSAFNCep
 
The clustering analysis was carried out only on
annotated TM proteins with an enrichment score
of greater than 0.5 in at least one of the three cell
types (U, A, M). These proteins then were clus-
tered on the basis of their enrichment scores in all
three cell types. An unsupervised hierarchical clus-
tering algorithm was applied using the Euclidean
distances of the score triplets using the ‘hclust’
R function with the ‘complete’ agglomeration
method. 8 clusters were selected and plotted in
Figure 3(a) and Table S3.
The proteomics datasets have been deposited in the
public proteomics repository MassIVE (Mass
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Spectrometry Interactive Virtual Environment), part
of the ProteomeXchange consortium [63], with the
identifier MSV000083166 (and PXD011856 for
ProteomeXchange) and is available through the fol-
lowing link: ftp://massive.ucsd.edu/MSV000083166.
Antibodies
The following primary antibodies were used for
Western blotting: Rabbit anti-calnexin (Sigma
#C4731), Rabbit anti-lamin B1 (made in-house),
Rabbit anti-LAP2β (made in-house), Rabbit anti-
H2B(V119) (Cell Signaling #8135S), Mouse anti-Tim
23 (BD Transduction Laboratories #611222), Rabbit
anti-Pex14 (Millipore #ABC142). In efforts to detect
the endogenous counterparts of the new NE-enriched
proteins on Western blots of whole C3H cell lysates,
we tested multiple commercial antibodies. These
included antibodies described in the Human Protein
Atlas <https://www.proteinatlas.org/> that gave NE
labeling (as well as substantial cytoplasmic and intra-
nuclear punctate staining) in some cell types by immu-
nofluorescence. However all of the antibodies labeled
multiple bands in the molecular weight ranges of
interest. Antibodies tested: Rabbit anti-Arl6ip6
(Thermo Fisher #PA5-48553), Rabbit anti-Tmx4
(Sigma #HPA015752), Rabbit anti-Smpd4 (Sigma
#HPA049426), Rabbit anti-Mfsd10 (Abcam
#ab170830).
The following antibodies were used for immuno-
fluorescence staining: Primary antibodies: mouse
anti-V5 (Invitrogen #46–0705), rabbit anti-V5
(Thermo Fisher #PA1-993), rabbit anti-calnexin
(Abcam #ab22595), guinea pig anti-lamin A (made
in-house), mouse anti-NPC RL1 (IgM [64],), mouse
anti-nesprin-1 (8C3, gift from Dr. Glenn E. Morris,
RJAH Orthopaedic Hospital, UK), mouse anti-
nesprin-1 (7A12, Millipore #MABT843), rabbit anti-
nesprin-2 (Invitrogen OR United States Biological
Corporation), rabbit anti-nesprin-3 (United States
Biological Corporation), rabbit anti-myosin heavy
chain (Abcam #124205). Secondary antibodies:
Alexa Flour 488 conjugated goat anti-mouse IgG
(H + L) (Invitrogen #A28175), Alexa Flour 568 con-
jugated goat anti-rabbit IgG (H + L) (Invitrogen
#A11036), Alexa Flour 647 conjugated goat anti-
guinea pig IgG (H + L) (Invitrogen #A21450), Alexa
Flour 488 conjugated goat anti-mouse Fc specific
(Jackson ImmunoResearch #115–545-008), Alexa
Fluor 568 conjugated goat anti-mouse IgM µ chain
(Invitrogen #A21043). DAPI (Sigma) was used to
stain DNA.
Molecular cloning
To construct lentiviral vectors containing V5-tagged
versions of our genes of interest, the following cDNA
clones were purchased: pCMV6-Arl6ip6 (Origene,
RefSeq BC019550), pCMV6-Tmx4 (Origene, RefSeq
NM_029148), pCMV6-Mfsd10 (Origene, RefSeq
NM_026660), pCMV6-Vrk2 (Origene, RefSeq
NM_027260), pcDNA3.1-eGFP-Smpd4 (Genscript,
RefSeq NM_029945), pcDNA3.1-ITPRIP-DYK
(Genscript, RefSeq NM_001272012). mCherry-Sec
61β was a gift from Gia Voeltz (Addgene plasmid
#49155). Lem2 and Emerin were cloned from plas-
mids previously constructed in our lab.
All genes were inserted into pLV-EF1a-IRES-
Puro (gift from Tobias Meyer, Addgene plasmid
#85132) using ligation independent cloning (LIC).
Two LIC-compatible sites, containing either an
N-terminal V5 tag or a C-terminal V5 tag, were
designed synthetically and inserted into pLV-EF
1a-IRES-Puro using restriction enzymes BamHI
and MluI. The primers used to insert the genes
of interest into the LIC-compatible pLV-EF1a-
IRES-Puro vector are listed in Supplementary
Table S4. The portion of the primer that aligns to
the gene of interest is underlined, and the portion
that is required for T4 Polymerase (T4P) digestion
during LIC is not underlined.
Genes of interest were amplified by PCR using
Phusion High-Fidelity DNA Polymerase (New
England Biolabs). pLV-EF1a-IRES-Puro LIC-
compatible vectors were digested with SrfI (New
England Biolabs). PCR fragments and SrfI-digested
vector were treated with T4 Polymerase (New
England Biolabs) in the presence of either dTTP
(PCR products) or dATP (vector). T4P-digested vec-
tor and inserts were mixed at room temperature for
5 minutes, and then NEB Stable Competent Cells
(New England Biolabs) were transformed with the
product. Cells were incubated at 30°C for 24 hours,
and then colonies were picked for clone validation. All
cDNA clones were confirmed by complete DNA
sequencing of the ORF in both 5'-3' and 3'-5
directions.
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Generation of stably transduced cell populations
To produce lentiviruses, 293T cells were seeded so
that they would be 60% confluent for transfection.
Medium was changed to DMEM supplemented with
10% FBS, 1% glutamine, and 1% NEAA without
antibiotics 30 minutes prior to transfection. Cells
were transfected with pRSV-REV (gift from Didier
Trono, Addgene plasmid #12253), pMDL-RRE (gift
from Didier Trono, Addgene plasmid #12251),
pCMV-VSVg (gift from Bob Weinberg, Addgene
plasmid #8454), and pLV-EF1a-gene-of-interest
(pLV-EF1a-GOI) vectors using Lipofectamine 2000
(Invitrogen). Viral supernatant was harvested
48 hours after transfection and filtered through
a 0.45 μm polyethersulfone membrane filter (GE
Healthcare Whatman).
C3H, C2C12, and U2OS cells were changed to
DMEM with 10% FBS, 1% glutamine, and 1%
NEAA without antibiotics. Cells were diluted to
5 × 104 cells/mL and polybrene (EMD Millipore)
was added to a final concentration of 10 μg/mL.
Cells were transduced with different viral loads
(ranging from 1 to 500 μL of viral supernatant
per 1 mL of cells) to obtain cell populations with
different multiplicities of infection (MOIs). After
3 days of viral transduction, cells were treated with
puromycin (Invivogen) to select for cells that had
successfully integrated viral DNA. C3H were trea-
ted with 5 μg/mL, C2C12 were treated with 5 μg/
mL, and U2OS were treated with 1 μg/mL puro-
mycin for up to 1 week. Cell populations were
further expanded and grown for fractionation,
Western blotting, and immunofluorescence.
Western blotting
For Western blotting, cells were resuspended in 2X
Laemmli buffer (4% SDS, 10% 2-mercaptoethanol,
20% glycerol, 0.004% bromophenol blue, and
0.125 M Tris-HCl pH 6.8) and boiled for 5 minutes.
Samples were run on a Novex Tris-Glycine gel (Life
Technologies) using FASTRun Buffer (Fisher
Scientific). Samples were then transferred to
a nitrocellulose membrane (Life Technologies).
Membranes were rinsed twice with Tris-buffered sal-
ine (TBS) with 0.1% Tween-20 (Tw) and then blocked
with 5% bovine serum albumin (BSA) in TBS/Tw.
Membranes were incubated with primary antibody
diluted in 0.5% BSA in TBS/Tw overnight at 4°C.
Membranes were then washed 6 times with TBS/Tw
and incubated with HRP conjugated secondary anti-
bodies in TBS/Tw for 1 hour at room temperature.
Signals were then developed using an enhanced che-
miluminescence kit (Thermo Fisher) for 5 minutes
and the signals were captured by UVP digital imaging
system.
Immunofluorescence
For immunofluorescence staining, cells were pla-
ted on sterile glass coverslips and allowed to
grow overnight. 24 hours after plating, cells
were rinsed with Dulbecco’s phosphate buffered
saline (DPBS with calcium and magnesium) and
fixed using 2% paraformaldehyde (PFA)
(Electron Microscopy Sciences) in DPBS for
20 minutes. Samples were rinsed three times
with phosphate buffered saline (PBS) and
blocked for 15 minutes in PBS with 5% goat
serum (Jackson ImmunoResearch Laboratories)
and 0.5% Triton X-100 (Tx) (Fisher Scientific).
Samples were then incubated with primary anti-
body diluted in PBS with 1% goat serum and
0.1% Tx overnight at 4°C. After washing with
PBS/Tx (0.1%) 4 times, samples were incubated
with Alexa Fluor conjugated secondary antibody
diluted in PBS/Tx (0.1%) at room temperature
for one hour. Samples were finally washed twice
with PBS/Tx (0.1%), incubated with DAPI at
room temperature for 10 minutes, and then
washed twice with PBS and mounted on glass
slides using Aqua-Poly Mount (Polysciences).
For digitonin permeabilization of C3H cells,
4 × 104 cells were plated on sterile glass coverslips
coated with 0.2% gelatin in a 24-well plate. 24 hours
later, cells were fixed and treated with either 40 μg/mL
or 1mg/mL digitonin in PBS at room temperature for
5 minutes. Samples were then washed 3 times with
PBS and blocked using PBS with 5% goat serum at
room temperature for 15minutes. Samples were incu-
bated with primary antibody diluted in PBS with 0.5%
goat serum overnight at 4°C. The next morning,
samples were washed 4 times with PBS and incubated
with secondary antibody in PBS for 1 hour at room
temperature. Samples were then stained with DAPI,
washed with PBS and mounted on glass slides using
Aqua-Poly Mount.
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Light microscopy and quantification
Confocal images were acquired on a Zeiss 780 or
a Zeiss 880 Airyscan laser-scanning confocal
microscope with a 63X PlanApo 1.4 NA objective.
Contrast adjustment of the representative images
was performed with ZEN software (Zeiss). 10 or
more images from each stably or transiently trans-
duced cell population of the lower expression
levels were randomly chosen and the NE/ER
ratio was quantified. Lamin A staining was used
to outline the nucleus and the area of NE and ER
were defined by −0.5 to 0 μm (NE) and +0.5 to +1
μm (ER) relative to the edge of the nucleus using
the ‘Enlarge’ function in ImageJ (NIH). Total
fluorescent intensities of V5 staining in both
areas were measured and normalized to the cal-
nexin staining of the same area. The ratio of NE/
ER was then calculated by dividing the normalized
V5 signals in the NE to the normalized V5 in
the ER.
The co-localization analysis was performed with
the ‘Coloc2’ function in ImageJ. Where necessary,
raw images was processed using the rolling-ball
‘background subtraction’ function in ImageJ.
Control and test images were processed with iden-
tical parameters. Representative images were pre-
pared with automatic Airyscan processing in ZEN.
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